Mometasone Furoate Market: By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Mometasone Furoate Market Size, Share, Growth, Trends, and Global Industry Analysis: By Dosage Form (Nasal Spray, Cream, Ointment, Inhalers, and Others), By Indication Type (Inflammatory Skin Disorders, Asthma, Allergic rhinitis, and Others), By Route of Administration (Nasal Administration, Topical, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Mometasone Furoate Market size was valued at US$ 1,288.3 million in 2024 and is expected to reach US$ 2,137.3 million by 2031, growing at a significant CAGR of 7.5% from 2025-2031. Mometasone also called mometasone furoate is a corticosteroid that is used to cure hay fever, asthma, and numerous skin issues. Instead of handling asthma attacks, mometasone furoate is used chiefly to avoid them. It prevents white blood cells (WBCs) which fight against infection from reaching the injured area. Mometasone reduces itching, redness, and inflammation. It hinders the chemical messenger, histamine, which is responsible for allergic reactions in the body. Symptoms of various skin allergies along with other allergic disorders like allergic rhinitis and hay fever are efficient for treatment by mometasone furoate. The rising prevalence of inflammatory skin diseases can lead to the market growth.

Moreover, the growth in the geriatric populace and growing personal aesthetics are some primary factors that can boost the global market. Apart from these, the rising patient populace suffering from asthma can also accelerate the market in the future. The growing cooperative research and development events among leading pharmaceutical filtration and biotechnological companies can also drive the global market further. However, some factors such as side effects related to mometasone furoates such as sore throat, headache, nose bleeds, muscle and joint pain, viral upper respiratory infections, and cough can restrain the growth of the market.

Mometasone Furoate Market Key Developments

  • In June 2022, Glenmark launched Indacaterol and Mometasone Fixed-Dose Combination Drug for the treatment of asthma and became the first pharmaceutical company
  • In May 2021, Glenmark launched Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis.

summary download arrow Download Sample

Mometasone Furoate Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

7.5%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Mometasone Furoate Market Dynamics

One of the major reasons for the global mometasone furoate market growth is the growing research and development actions connected to mometasone furoate. According to the research published in the Journal of Dermatological Treatment, March 2022, a study was conducted to develop aspasomal mometasone furoate gel that delivers medicine at a controlled rate, needs nominal doses to cure psoriasis, and is biologically active. Aspasomal gel along with mometasone furoate was formulated and it was observed that aspasomal gel along with mometasone furoate delivered the medicine after a longer time period and needed fewer doses, increasing the possibility of psoriasis treatment.

Mometasone Furoate Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 1,288.3 million

Market Size in 2031

US$ 2,137.3 million

Market CAGR

7.5%

By Dosage Form

  • Nasal Spray
  • Cream
  • Ointment
  • Inhalers
  • Others

By Indication Type

  • Inflammatory Skin Disorders
  • Asthma
  • Allergic rhinitis
  • Others

By Route Administration

  • Nasal Administration
  • Topical
  • Oral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The mometasone furoate market report provides granular level information about the market size, regional market share, historic market (2020 to 2024), and forecast (2025 to 2031)
  • The report covers in-detail insights into the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The mometasone furoate market size was valued at US$ 1,288.3 million in 2024 and is expected to reach US$ 2,137.3 million by 2031, growing at a significant CAGR of 7.5% from 2025-2031.

Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., Hikma Pharmaceuticals

North America is the fastest-growing region in the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Mometasone Furoate Market Introduction
2.1. Global Mometasone Furoate Market Taxonomy
2.2. Global Mometasone Furoate Market Definitions
2.2.1. Dosage Form
2.2.2. Indication Type
2.2.3. Route of administration
2.2.4. Distribution Channel
2.2.5. By Region
3. Global Mometasone Furoate Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Mometasone Furoate Market Dynamic Factors - Impact Analysis
3.6. Global Mometasone Furoate Market Competition Landscape
3.7. Epidemiology
4. Global Mometasone Furoate Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Mometasone Furoate Market, By Dosage Form, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.1. Nasal Spray
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Cream
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Ointment
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Inhalers
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Mometasone Furoate Market, By Indication Type, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.1. Inflammatory Skin Disorders
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Asthma
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Allergic rhinitis
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Mometasone Furoate Market, By Route of Administration, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.1. Nasal Administration
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Topical
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Oral
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Mometasone Furoate Market, By Distribution Channel, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Pharmacies
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Mometasone Furoate Market Forecast, By Region, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Region, 2025 - 2031
10. North America Mometasone Furoate Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
10.1. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Nasal Spray
10.1.2. Cream
10.1.3. Ointment
10.1.4. Inhalers
10.1.5. Others
10.2.  Indication Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Inflammatory Skin Disorders
10.2.2. Asthma
10.2.3. Allergic rhinitis
10.2.4. Others
10.3. Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Nasal Administration
10.3.2. Topical
10.3.3. Oral
10.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2025 - 2031
10.7. North America Mometasone Furoate Market Dynamics Trends
11. Europe Mometasone Furoate Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
11.1. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Nasal Spray
11.1.2. Cream
11.1.3. Ointment
11.1.4. Inhalers
11.1.5. Others
11.2.  Indication Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Inflammatory Skin Disorders
11.2.2. Asthma
11.2.3. Allergic rhinitis
11.2.4. Others
11.3. Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Nasal Administration
11.3.2. Topical
11.3.3. Oral
11.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2025 - 2031
11.7. Europe Mometasone Furoate Market Dynamics Trends
12. Asia-Pacific Mometasone Furoate Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
12.1. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Nasal Spray
12.1.2. Cream
12.1.3. Ointment
12.1.4. Inhalers
12.1.5. Others
12.2.  Indication Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Inflammatory Skin Disorders
12.2.2. Asthma
12.2.3. Allergic rhinitis
12.2.4. Others
12.3. Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Nasal Administration
12.3.2. Topical
12.3.3. Oral
12.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2025 - 2031
12.7. Asia-Pacific Mometasone Furoate Market Dynamics Trends
13. Latin America Mometasone Furoate Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
13.1. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Nasal Spray
13.1.2. Cream
13.1.3. Ointment
13.1.4. Inhalers
13.1.5. Others
13.2.  Indication Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Inflammatory Skin Disorders
13.2.2. Asthma
13.2.3. Allergic rhinitis
13.2.4. Others
13.3. Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Nasal Administration
13.3.2. Topical
13.3.3. Oral
13.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Mometasone Furoate Market - Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2025 - 2031
13.7. Latin America Mometasone Furoate Market Dynamics Trends
14. Middle East and Africa Mometasone Furoate Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
14.1. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Nasal Spray
14.1.2. Cream
14.1.3. Ointment
14.1.4. Inhalers
14.1.5. Others
14.2.  Indication Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Inflammatory Skin Disorders
14.2.2. Asthma
14.2.3. Allergic rhinitis
14.2.4. Others
14.3. Route of Administration Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.3.1. Nasal Administration
14.3.2. Topical
14.3.3. Oral
14.4. Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Mometasone Furoate Market- Opportunity Analysis Index, By Dosage Form, By Indication Type, By Route of Administration, By Distribution Channel, and Country, 2025 - 2031
14.7. MEA Mometasone Furoate Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Dosage Forms, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Cipla
15.2.2. Teva Pharmaceuticals
15.2.3. Glenmark Pharmaceuticals
15.2.4. AdvaCare Pharma
15.2.5. Medlab Pharmaceuticals Private Limited
15.2.6. Dermocare Laboratories
15.2.7. Iva Healthcare Private Limited
15.2.8. Organon group of companies
15.2.9. Cosette Pharmaceuticals
15.2.10. Taro Pharmaceutical Industries Ltd.
15.2.11. Hikma Pharmaceuticals
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Cipla
  • Teva Pharmaceuticals
  • Glenmark Pharmaceuticals
  • AdvaCare Pharma
  • Medlab Pharmaceuticals Private Limited
  • Dermocare Laboratories
  • Iva Healthcare Private Limited
  • Organon group of companies
  • Cosette Pharmaceuticals
  • Taro Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals

Related Industry Reports

Upadacitinib API Market

Opicapone API Market

Darolutamide API Market

Medical Batteries Market